| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Director, 10%+ Owner | Common Units | 111M | $1.19B | $10.78 | May 28, 2024 | Indirect |
| Sotera Health Co | Director, 10%+ Owner | Common Stock, $0.01 par value per share ("Common Stock") | 22.7M | $371M | $16.33 | Dec 3, 2025 | Indirect |
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Director, 10%+ Owner | Class A common stock | 20.2M | $198M | $9.82 | May 28, 2024 | Indirect |
| Vivid Seats Inc. | 10%+ Owner | Class A Common Stock | 3.77M | $62.7M | $16.64 | Oct 31, 2025 | Indirect |
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Director, 10%+ Owner | Class B common stock | 111M | May 28, 2024 | Indirect | ||
| Paya Holdings Inc. | Director, 10%+ Owner | Common Stock | 0 | $9.75 | Feb 22, 2023 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SHC | Sotera Health Co | Dec 3, 2025 | 1 | -$106M | 4 | Dec 5, 2025 | Director, 10%+ Owner |
| SHC | Sotera Health Co | Nov 10, 2025 | 1 | -$188M | 4 | Nov 12, 2025 | Director, 10%+ Owner |
| SEAT | Vivid Seats Inc. | Oct 31, 2025 | 0 | $0 | 3 | Nov 7, 2025 | 10%+ Owner |
| SHC | Sotera Health Co | Sep 5, 2025 | 1 | -$121M | 4 | Sep 9, 2025 | Director, 10%+ Owner |
| SHC | Sotera Health Co | Sep 6, 2024 | 1 | -$150M | 4 | Sep 9, 2024 | Director, 10%+ Owner |
| MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | May 28, 2024 | 4 | -$97.6M | 4 | May 30, 2024 | Director, 10%+ Owner |
| SHC | Sotera Health Co | Mar 4, 2024 | 1 | -$158M | 4 | Mar 6, 2024 | Director, 10%+ Owner |
| PAYA | Paya Holdings Inc. | Feb 22, 2023 | 1 | -$441M | 4 | Feb 22, 2023 | Director, 10%+ Owner |
| MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | Jan 22, 2023 | 2 | $0 | 4 | Jan 24, 2023 | Director, 10%+ Owner |
| MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | Dec 31, 2021 | 2 | $0 | 4 | Jan 4, 2022 | Director, 10%+ Owner |
| MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | Sep 9, 2021 | 3 | -$1B | 4 | Sep 13, 2021 | Director, 10%+ Owner |